Bearish flow noted in Travere Therapeutics (TVTX) with 7,024 puts trading, or 1.8x expected. Most active are Mar-26 25 puts and Apr-26 22.5 puts, with total volume in those strikes near 5,600 contracts. The Put/Call Ratio is 40.37, while ATM IV is up nearly 3 points on the day. Earnings are expected on February 19th.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TVTX:
- Travere Therapeutics price target lowered to $43 from $47 at BofA
- Buy Rating Reaffirmed on Travere Therapeutics: Attractive Risk/Reward Despite FDA Delay and Near‑Term Catalyst Reset
- Top 5 Trending Stocks by Unusual Trading Volume, 1/14/26
- FDA Extends Review Timeline for Travere’s FILSPARI sNDA
- Leerink says Travere’s Filspari PDUFA extension removes worst case scenario